Head-to-head · WeighScore
ARSYNL Rx vs EdgeRx
By GLP-1 ScorecardUpdated
Score comparison
EdgeRx has the higher recorded score — 79/100 to 59.1/100.
EdgeRx grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. EdgeRx lists compounded GLP-1 injections in a men’s health program. Its terms say the final charge can vary with the prescription and pharmacy.
Before you choose
Before comparing the headline prices, the ARSYNL Rx review and the EdgeRx review set out the plan length, renewal date and extra fees behind each semaglutide figure in the table below, and the semaglutide cost page compares published rates across the field. A lower starting price can still mean a larger bill once a longer commitment or a separate membership is added.
If neither one fits, ARSYNL Rx vs FMmeds and Care Clinics vs EdgeRx compare each of them with another graded program, and the list of alternatives to ARSYNL Rx ranks the programs closest to ARSYNL Rx on price, features and score. Those pages, like every entry in the review directory, use the same six graded factors, so the scores carry across.
Of the sellers that pay us a commission, the MyDrHank review covers one graded close to these two, at 68.2/100. That relationship never changes a grade, and the review lists what we could not verify.
We may earn a commission through these links, at no extra cost to you. Commercial relationships affect placement, but never the WeighScore or our editorial findings. See our disclosure.
Factor by factor
These are recorded editorial marks, not a measure of clinical outcomes. Current prices and terms may differ from those used in the marks. See the methodology.
The numbers
Swipe or scroll to compare both providers.
| Metric | ARSYNL Rx | EdgeRx |
|---|---|---|
| WeighScore | 59.1/100 | 79/100 |
| Grade | C | C+ |
| Site position | #382 | #42 |
| Semaglutide | $219/mo (advertised, compounded; confirm selected quote) | Advertised $199/mo; confirm final prescription charge |
| Tirzepatide | $269/mo (advertised, compounded with B12; confirm selected quote) | Advertised $225/mo; confirm final prescription charge |
| Coverage | Advertises nationwide service; confirm selected treatment availability | 47 states advertised; excludes Arkansas, Indiana and South Carolina |
| Brand-name access | Not confirmed | Not confirmed |
| Oral / sublingual | Not confirmed | Not confirmed |
Strengths
- Publishes separate injection product pages
- Advertises clinician review and shipping
- Publishes the carrier handoff point in its returns policy
What to consider
- The general program starting price does not identify the selected product
- Paid orders are final after carrier handoff
- Selected treatment availability and renewal need confirmation
Strengths
- Publishes separate semaglutide and tirzepatide prices
- Names Strive as its primary 503A pharmacy in its terms
- Advertises included shipping and physician review
What to consider
- The final charge may vary with the prescribed product and dispensing pharmacy
- The homepage’s approval refund language needs to be reconciled with the consultation fee and final-sale terms
Featured provider
CoreAge Rx
CoreAge Rx scores 89.5/100 (B+). Advertises pricing across doses with no membership fee, but starting-price displays and FAQ payment/refund promises need to be reconciled with the selected plan and refund policy.
Commercial relationships affect this placement. The score comparison above is separate.
Prices and terms can change; confirm them with the provider. Our factor scores may reflect earlier assessments; see our methodology. Not medical advice; see our disclosure.